Malaria vaccine
GSK boosts vaccine production with €250M facility for shingles, RSV and malaria shots
Anika Sharma
As GlaxoSmithKline (GSK) continues to expand its vaccine portfolio with the introduction of the new respiratory syncytial virus (RSV) vaccine, ...
